Diabetes Care, Vol 20, Issue 10 1547-1552, Copyright © 1997 by American Diabetes Association

ARTICLES

Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry

CL Vandewalle, A Falorni, A Lernmark, P Goubert, H Dorchy, W Coucke, C Semakula, B Van der Auwera, L Kaufman, FC Schuit, DG Pipeleers and FK Gorus
Diabetes Research Center, Vrije Universiteit Brussel, Belgium.

OBJECTIVE: To investigate the association of GAD (65-kDa) autoantibodies (GAD65-Abs) and IA-2 autoantibodies (IA-2-Abs) with human leukocyte antigen (HLA)-DQ and insulin gene (INS) risk markers in patients with recent-onset IDDM and their siblings. RESEARCH DESIGN AND METHODS: Blood was sampled from 608 recent-onset IDDM patients and 480 siblings, aged 0-39 years and consecutively recruited by the Belgian Diabetes Registry, to determine GAD65- and IA-2-Ab (radiobinding assay), HLA-DQ- (allele-specific oligonucleotyping), and INS-genotypes (restriction fragment length polymorphism analysis; siblings, n = 439). RESULTS: At the onset of IDDM, GAD65-Abs were preferentially associated with two populations at genetic risk but only in the 20- to 39-year age-group: 1) their prevalence was higher in carriers of DQA1*0301-DQB1*0302 (88 vs. 73% in non[DQA1*0301-DQB1*0302], P = 0.001), and 2) an association was found in patients lacking this haplotype but carrying DQA1*0501-DQB1*0201, together with INS I/I (87 vs. 54% vs. non[INS I/I], P = 0.003). Siblings of IDDM patients also presented the association of GAD65-Abs with DQA1*0301-DQB1*0302 (13 vs. 2% non[DQA1*0301-DQB1*0302], P < 0.001), while associations with the second genetic risk group could not yet be assessed. At the onset of IDDM, IA-2-Ab prevalence was higher in carriers of DQA1*0301-DQB1*0302 (69 vs. 39% non[DQA1*0301-DQB1*0302], P < 0.001) but not of DQA1*0501-DQB1*0201 or INS I/I. This association was present in both the 0- to 19- and the 20- to 39-year age-groups. It was also found in siblings of IDDM patients (4 vs. 0% non[DQA1*0301-DQB1*0302], P < 0.001). CONCLUSIONS: Both GAD65- and IA-2-Abs exhibit higher prevalences in presence of HLA-DQ- and/or INS-genetic risk markers. Their respective associations differ with age at clinical onset, suggesting a possible usefulness in the identification of subgroups in this heterogeneous disease.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. E.M. De Block, I. H. De Leeuw, J. J.P.M. Bogers, P. A. Pelckmans, M. M. Ieven, E. A.E. Van Marck, K. L. Van Acker, and L. F. Van Gaal Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies: Histological and clinical findings Diabetes Care, January 1, 2003; 26(1): 82 - 88. [Abstract] [Full Text] [PDF]

				G. Stenstrom, B. Berger, H. Borg, P. Fernlund, J. S. Dorman, and G. Sundkvist HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult Am. J. Epidemiol., November 1, 2002; 156(9): 787 - 796. [Abstract] [Full Text] [PDF]

				I. Weets, V. Siraux, J.-C. Daubresse, I. H. De Leeuw, F. Fery, B. Keymeulen, G. Krzentowski, M. Letiexhe, C. Mathieu, F. Nobels, et al. Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2597 - 2605. [Abstract] [Full Text] [PDF]

				M. Schlosser, M. Strebelow, R. Wassmuth, M.-L. Arnold, I. Breunig, I. Rjasanowski, B. Ziegler, and M. Ziegler The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of {beta}-Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive Individuals J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2254 - 2261. [Abstract] [Full Text] [PDF]

				J. Graham, W. A. Hagopian, I. Kockum, L. S. Li, C. B. Sanjeevi, R. M. Lowe, J. B. Schaefer, M. Zarghami, H. L. Day, M. Landin-Olsson, et al. Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes Diabetes, May 1, 2002; 51(5): 1346 - 1355. [Abstract] [Full Text] [PDF]

				C. E. M. De Block, I. H. De Leeuw, K. Decochez, F. Winnock, J. Van Autreve, C. M. Van Campenhout, M. Martin, and F. K. Gorus The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4358 - 4363. [Abstract] [Full Text] [PDF]

				G. Gambelunghe, M. Ghaderi, C. Tortoioli, A. Falorni, F. Santeusanio, P. Brunetti, C. B. Sanjeevi, and A. Falorni Two Distinct MICA Gene Markers Discriminate Major Autoimmune Diabetes Types J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3754 - 3760. [Abstract] [Full Text] [PDF]

				B. Rubi, H. Ishihara, F. G. Hegardt, C. B. Wollheim, and P. Maechler GAD65-mediated Glutamate Decarboxylation Reduces Glucose-stimulated Insulin Secretion in Pancreatic Beta Cells J. Biol. Chem., September 21, 2001; 276(39): 36391 - 36396. [Abstract] [Full Text] [PDF]